Anglesio et al., using whole-genome and targeted deep sequencing, found concurrent ARID1A and PIK3CA mutations in ovarian clear cell carcinoma and in tumor-adjacent and distant endometriotic lesions, independently of cytological atypia [123]. This evidence concerns the gene PIK3CA and ovarian clear cell cancer.